Spironolactone may be safe to treat female pattern hair loss in breast cancer survivors

Spironolactone is not associated with increased risk of female breast cancer recurrence, according to research from the George Washington University Department of Dermatology.

from News Medical Medical Research News Feed https://ift.tt/33d7AOp